| Resume a previously saved form
Resume Later

In order to be able to resume this form later, please enter your email and choose a password.

Step 1

Prostate Cancer Foundation of Australia Logo

Prostate Cancer Foundation of Australia Review of the Clinical Practice Guidelines for PSA Testing

Public Comment Period

This consultation is seeking written submissions from Australians who wish to comment on the 2016 Clinical Practice Guidelines for Prostate Specific Antigen (PSA) Testing and Early Management of Test-detected Prostate Cancer (the 2016 Guidelines).
Submissions will be used to inform the development of revised guidelines to be released in 2025. 

This public consultation aligns with the National Health and Medical Research Council endorsed process for guideline review. The process is overseen by a Project Steering Committee comprising consumer, community and industry representatives, a 51 member multi-disciplinary Expert Advisory Panel (EAP) and 12 EAP Working Groups.
The deadline for comments is 5pm on Friday 31 May, 2024.

Click here for more information on the public comment period.

You can make a submission by completing this form online, or sending your comments via email or post (click here to download a PDF copy of the survey questions). Please send correspondence to the addresses provided below.
Submit via email:
Submit via post:
To the Steering Committee
Review of Guidelines for PSA Testing
PO Box 499
St Leonards NSW 1590
Privacy Information

Any personal information collected via this website will be stored and used in accordance with PCFA’s obligations under the Privacy Act 1988, and in accordance with the PCFA Privacy Policy. All information collected will be de-identified for reporting purposes.

* indicates a required field

Step 2

Personal / organisational information 

Please select any that apply

* indicates a required field

Step 3

Questions about the 2016 Guidelines
Below are some general questions on the 2016 Guidelines. You don’t need to answer all sections or questions, only ones that are of interest to you.